Pajjiż: Malta
Lingwa: Ingliż
Sors: Medicines Authority
PHENAZONE
Rowa Pharmaceuticals Limited Newtown, Bantry, Co. Cork, Ireland
N02BB01
PHENAZONE 5 % (W/V)
EAR DROPS, SOLUTION
PHENAZONE 5 % (W/V)
OTC
ANALGESICS
Authorised
2005-11-23
Page 1 of 3 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Tropex 5% w/v Ear Drops Solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1 ml solution contains Phenazone 50mg (5% w/v) Each ml also contains 1mg methylparahydroxybenzoate For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Ear drops solution. Clear, colour less solution. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS_ _ For the management of the symptoms of otitis media and other inflammatory conditions of the ear. Also for the softening and removal of earwax. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Route of Administration: Topical into external auditory canal. Recommended Dosage Schedule: 4-6 drops to be introduced into the ear three to four times a day according to the severity of the inflammation. 4.3 CONTRAINDICATIONS TROPEX Ear Drops should not be used in patients who have perforated eardrums or in patients who are hypersensitive to the ingredients. 4.4 SPECIAL WARNINGS AND SPECIAL PRECAUTIONS FOR USE If improvement does not occur within 24 hours the doctor should be consulted. If infection is present the doctor should be consulted. 4.5 INTERACTIONS WITH OTHER MEDICAMENTS AND OTHER FORMS OF INTERACTION _ _ Oral Phenazone affects the metabolism of drugs broken down by liver enzymes. However, little absorption is expected from topical application into the auditory canal. 4.6 PREGNANCY AND LACTATION There is no information to contraindicate the use of TROPEX Ear Drops during preg Aqra d-dokument sħiħ